Free Practice Questions for NM MPJE

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card

321+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More MPJE Pharmacy Jurisprudence

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

More From This Family

Videos and articles for deeper review.

VideoFree MPJE Practice Test by State 2026: 5,000+ Pharmacy Law Questions ArticleFree MPJE Practice Test by State 2026: 5,000+ Pharmacy Law Questions18 min read

Exam Review

Key Facts: NM MPJE Exam

120

Exam Questions

100 scored + 20 pretest

Passing Score

Scaled score

2.5 hrs

Time Limit

NABP

30 CE

Renewal CE Hours

Per biennium

7-day

Initial Opioid Limit

NM acute pain

Immunization Age

NM pharmacist authority

The NM MPJE covers federal pharmacy law (DEA, FDA, CSA, HIPAA) and New Mexico-specific regulations including the NM PDMP, expanded pharmacist prescriptive authority, hormonal contraceptive prescribing, telepharmacy for rural areas, and 30 contact hours CE per biennial renewal. The NM Board of Pharmacy operates under the Regulation and Licensing Department.

Sample NM MPJE Practice Questions

Try these sample questions to review concepts for the NM MPJE exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 321+ question experience with AI tutoring.

1Under the Controlled Substances Act (CSA), which schedule contains drugs with a high potential for abuse but currently accepted medical use, such as oxycodone and fentanyl?

A.Schedule I

B.Schedule II

C.Schedule III

D.Schedule IV

Explanation: Schedule II controlled substances have a high potential for abuse but have currently accepted medical use. Abuse may lead to severe psychological or physical dependence. Examples include oxycodone, fentanyl, morphine, methylphenidate, and amphetamine salts.

2Under federal law, a pharmacist must verify all of the following on a controlled substance prescription EXCEPT:

A.Patient's full name and address

B.Prescriber's DEA registration number

C.Patient's insurance information

D.Date the prescription was issued

Explanation: Federal law requires controlled substance prescriptions to include the patient's full name and address, prescriber's name/address/DEA number, drug name/strength/quantity, directions for use, and date of issuance. Insurance information is not a federal prescription requirement, though it may be needed for billing.

3The FDA's Abbreviated New Drug Application (ANDA) process allows generic drug manufacturers to:

A.Skip all clinical testing

B.Demonstrate bioequivalence to a reference listed drug without repeating full clinical trials

C.Market drugs without FDA approval

D.Use any inactive ingredient without restriction

Explanation: The ANDA process, established by the Hatch-Waxman Act, allows generic manufacturers to seek FDA approval by demonstrating bioequivalence to a reference listed drug. They do not need to repeat the extensive clinical trials conducted for the innovator drug but must show the generic has the same active ingredient, strength, dosage form, and route of administration.

4Under the Controlled Substances Act, which DEA form is used for the destruction of controlled substances?

A.DEA Form 41

B.DEA Form 106

C.DEA Form 222

D.DEA Form 224

Explanation: DEA Form 41 (Registrants Inventory of Drugs Surrendered) is used when a registrant wishes to dispose of or destroy controlled substances. The substances may be surrendered to a DEA-registered reverse distributor or destroyed in the presence of authorized witnesses. DEA Form 106 is for theft/loss, Form 222 for Schedule II orders, and Form 224 for new registration.

5Under HIPAA's Privacy Rule, a 'covered entity' includes all of the following EXCEPT:

A.A retail pharmacy

B.A health insurance plan

C.A pharmaceutical manufacturer

D.A healthcare clearinghouse

Explanation: HIPAA covered entities include healthcare providers who transmit health information electronically (such as pharmacies), health plans, and healthcare clearinghouses. Pharmaceutical manufacturers are generally not considered covered entities unless they also function as a health plan or provider. However, they may be business associates of covered entities.

6Under the Poison Prevention Packaging Act, a patient may request non-child-resistant packaging for their prescriptions. This request must be:

A.Approved by the prescriber

B.Made in writing and documented for each prescription

C.Submitted to the state board of pharmacy

D.Made on a per-prescription basis or as a blanket authorization

Explanation: Under the PPPA, a patient (or prescriber) may request non-child-resistant packaging. The request can be made on a per-prescription basis or as a blanket authorization covering all future prescriptions. The pharmacy must document the request. Prescribers may also authorize non-child-resistant packaging on the prescription.

7Which federal law requires pharmacies to maintain patient profiles for Medicaid recipients and offer counseling?

A.HIPAA

B.OBRA '90

C.DSHEA

D.PPPA

Explanation: The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) mandates that pharmacies serving Medicaid patients maintain patient profiles and offer counseling on new prescriptions. Although only required for Medicaid patients at the federal level, most states have extended these requirements to all patients.

8A pharmacy receives a prescription for tramadol. Under current federal scheduling, tramadol is classified as:

A.Schedule II

B.Schedule III

C.Schedule IV

D.Not a scheduled substance

Explanation: Tramadol was classified as a Schedule IV controlled substance by the DEA effective August 18, 2014. Schedule IV substances have a lower potential for abuse relative to Schedule III and have accepted medical use. As a Schedule IV drug, tramadol prescriptions may be refilled up to 5 times within 6 months.

9Under the Drug Quality and Security Act (DQSA) of 2013, outsourcing facilities registered under Section 503B must:

A.Only compound patient-specific prescriptions

B.Register with the FDA and comply with cGMP requirements

C.Be licensed only in their home state

D.Compound only non-sterile preparations

Explanation: The DQSA established Section 503B outsourcing facilities that can compound drugs without patient-specific prescriptions. These facilities must register with the FDA, comply with current Good Manufacturing Practice (cGMP) requirements, be inspected by the FDA, and report adverse events. This distinguishes them from traditional 503A compounding pharmacies.

10Under the Affordable Care Act (ACA), preventive health services including certain immunizations must be covered by health plans:

A.With a $50 copay

B.Without cost-sharing when provided by in-network providers

C.Only for patients over 65

D.Only when prescribed by a physician

Explanation: The ACA requires non-grandfathered health plans to cover recommended preventive services, including ACIP-recommended immunizations, without cost-sharing (copays, coinsurance, or deductibles) when provided by in-network providers. This has expanded the role of pharmacists in providing vaccinations.

About the NM MPJE Exam

The New Mexico MPJE tests knowledge of federal pharmacy law and New Mexico-specific pharmacy regulations. Required alongside the NAPLEX for pharmacist licensure in New Mexico. The exam is computer-adaptive with 120 questions (100 scored, 20 pretest).

Exam sponsor: NABP / NM Board of Pharmacy. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Questions

120 questions

Time Limit

2.5 hours

Passing Score

75 (scaled score)

Exam / Certification Fees

$250

Exam sponsor website

Reported exam pass rate: Not publicly reported. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Official sources

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

22%

Licensure & Personnel

Pharmacist qualifications, intern/technician requirements, license renewal, disciplinary actions

33%

Pharmacist Practice

Prescription requirements, counseling, prescriptive authority, collaborative practice agreements

24%

Dispensing Requirements

Generic substitution, prescription transfers, DUR, labeling, NM PDMP compliance

21%

Pharmacy Operations

Controlled substance records, compounding, pharmacy permits, telepharmacy, automated dispensing

Preparing for the NM MPJE Exam

What You Need to Know

Passing score: 75 (scaled score)
Exam length: 120 questions
Time limit: 2.5 hours
Exam / certification fees: $250 Official sources

Using Our Practice Resources

Work through all 321 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

NM MPJE: Suggested Study Strategy

1Master New Mexico's expanded pharmacist prescriptive authority and collaborative practice agreements

2Know NM's PDMP requirements and when checking is mandatory before prescribing or dispensing

3Study NM telepharmacy regulations for rural healthcare access

4Understand NM CE requirements: 3.0 CEU biennial, with 0.2 CEU of NM pharmacy law

5Review NM pharmacy technician certification requirements (nationally certified within 2 years)

Frequently Asked Questions

What is the NM MPJE exam format?

The NM MPJE is a computer-adaptive test with 120 questions (100 scored, 20 pretest). You have 2.5 hours to complete the exam. Questions cover federal pharmacy law and New Mexico-specific regulations. A scaled score of 75 or higher is required to pass.

What New Mexico-specific topics are tested on the NM MPJE?

Key NM-specific topics include expanded pharmacist prescriptive authority (including hormonal contraceptives), the NM PDMP, telepharmacy regulations for rural areas, 7-day initial opioid supply limit, pharmacist immunization authority for patients 7+, and 3.0 CEU (30 contact hours) per biennial renewal with 0.2 CEU of NM law.

How do I register for the NM MPJE?

Register through NABP at nabp.pharmacy. Create an e-Profile, apply for the NM MPJE, pay the exam fee ($100 application + $150 exam fee), and schedule your test at a Pearson VUE testing center. You must also apply for licensure with the NM Board of Pharmacy.

Does New Mexico allow pharmacist prescriptive authority?

Yes, New Mexico was one of the first states to grant pharmacist prescriptive authority through collaborative practice agreements. Pharmacists can also independently prescribe self-administered hormonal contraceptives under established protocols.

What happens if I fail the NM MPJE?

If you fail, you must wait at least 30 days before retaking the exam. Reapplication and fees are required for each attempt. Review your weak areas using the NABP competency statements and focus on both federal and NM-specific pharmacy law.

What is New Mexico's telepharmacy program?

New Mexico permits telepharmacy practice under Board-approved protocols to provide pharmacy services to underserved rural areas. A licensed pharmacist remotely supervises pharmacy operations using audio-visual technology, helping to expand access to pharmaceutical care in remote communities.

Free Practice Questions for NM MPJE

New Mexico MPJE Pharmacy Jurisprudence

Explore More MPJE Pharmacy Jurisprudence

New Jersey MPJE Pharmacy Jurisprudence

Massachusetts MPJE Pharmacy Jurisprudence

Alabama MPJE Pharmacy Jurisprudence

Tennessee MPJE Pharmacy Jurisprudence

Illinois MPJE Pharmacy Jurisprudence

Minnesota MPJE Pharmacy Jurisprudence